Locoid C ointment

Valsts: Lielbritānija

Valoda: angļu

Klimata pārmaiņas: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktīvā sastāvdaļa:

Chlorquinaldol; Hydrocortisone butyrate

Pieejams no:

Astellas Pharma Ltd

ATĶ kods:

D07BB04

SNN (starptautisko nepatentēto nosaukumu):

Chlorquinaldol; Hydrocortisone butyrate

Deva:

30mg/1gram ; 1mg/1gram

Zāļu forma:

Cutaneous ointment

Ievadīšanas:

Cutaneous

Klase:

No Controlled Drug Status

Receptes veids:

Valid as a prescribable product

Produktu pārskats:

BNF: 13040000

Lietošanas instrukcija

PACKAGE LEAFLET: INFORMATION FOR THE USER
LOCOID
® OINTMENT
Hydrocortisone butyrate 0.1% w/w
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor, pharmacist or
nurse.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even
if their signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Locoid Ointment is and what it is used for
2. What you need to know before you use Locoid Ointment
3. How to use Locoid Ointment
4. Possible side effects
5. How to store Locoid Ointment
6. Contents of the pack and other information
1. WHAT LOCOID OINTMENT IS AND WHAT IT IS USED FOR
Locoid Ointment contains the active substance hydrocortisone butyrate.
This is a corticosteroid
which when made up as an ointment is for use on the skin. This is
known as topical application.
Topical corticosteroids are ranked as mildly potent, moderately
potent, potent and very potent; Locoid
Ointment is classed as potent. Topical corticosteroids are able to
reduce the inflammation caused
by a variety of skin conditions, and so allow it to get better. They
can also affect the cause of the
condition, which can lead to its healing.
Locoid Ointment is indicated in adults, children and infants. It is
used to treat a variety of skin
conditions that respond to topical corticosteroids. Among these are
eczema and dermatitis (itching)
of all types including atopic (childhood) eczema, photodermatitis
(itching caused by exposure to light)
and dermatitis caused by skin irritants and allergies.
It can also be used in the treatment of psoriasis, a condition
resulting in thickening of areas of the
skin. It is important that you follow your doctor’s instructions
particu

Produkta apraksts

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Locoid Ointment
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Locoid Ointment contains 0.1% w/w hydrocortisone butyrate.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Ointment.
The product is a translucent, light grey to whitish, soft fatty
ointment.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Locoid Ointment is indicated in adults, children and infants. The
product is
recommended for clinical use in the treatment of conditions responsive
to
topical corticosteroids e.g. eczema, dermatitis and psoriasis.
Topical corticosteroids are not generally indicated in psoriasis but
may be
acceptable in psoriasis excluding widespread plaque psoriasis provided
warnings are given, see section 4.4 Special warnings and precautions
for use.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults and older people _
The same dose is used for adults and older people, as clinical
evidence would
indicate that no special dosage regimen is necessary in older people.
_Children_
Long term treatment should be avoided where possible.
_Infants _
Therapy should be limited if possible to a maximum of seven days.
Method of administration
For cutaneous use.
Dosage: To be applied evenly and sparingly no more than twice daily.
Application may be made under occlusion in the more resistant lesions
such as
thickened psoriatic plaques on elbows and knees.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in
section 6.1.
This preparation is contraindicated in the presence of untreated viral
or fungal
infections, tubercular or syphilitic lesions, peri-oral dermatitis,
acne vulgaris
and rosacea and in bacterial infections unless used in connection with
appropriate chemotherapy.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
As with all corticosteroids, application to the face, flexures and
other areas of thin
skin may cause skin atrophy and increased absorption and should be
avoided.
Topical corticosteroids may